<aside> 👉 This is a live document and will continue to be updated as necessary. Last update: Friday 6 November 2020 Original shared 27/10/20.

</aside>

Intro

With multiple vaccine candidates in Phase III and confirmation the NHS needs to be ready to start roll out in December, the NHS needs to prepare for rapid and effective delivery of the vaccine to millions of patients at the highest risk.

This briefing was written by accuRx to envisage how the vaccine delivery programme might play out and articulate what role our software platform could play in supporting this vital programme. Ours is a universal patient communication platform, used and loved by 98% of English GP practices, with full GP clinical system integration.

Even marginal gains of a percentage point here and there can add up to huge benefits for the NHS and society: helping us protect the vulnerable sooner, save lives and ultimately restore healthcare and economic activity sooner. Our briefing offers a set of ideas about how we can approach the invitation, booking, and vaccine administration process, and where we could help achieve the goals of the programme, making it more effective and more efficient.

This is a fast moving area. We're keeping this document up to date as we go. We're posting a changelog in the comments at the top. We appreciate a lot of work has already commenced and is not shared publicly yet, and is subject to considerable uncertainty. What follows is not designed to criticise anything that has been designed differently. We're sure there are constraints faced by the programme's leaders, the logistical clinical characteristics of the vaccine and outcomes after being administered.

We're sharing this paper with:

<aside> 🙋‍♂️ Please read this as an offer to discuss and to help where we can.

</aside>

Vaccine delivery process and challenges

Some of the key stages of vaccine delivery, where accuRx's software platform can help achieve programme goals
JCVI = Joint Committee on Vaccination and Immunisation

Some of the key stages of vaccine delivery, where accuRx's software platform can help achieve programme goals JCVI = Joint Committee on Vaccination and Immunisation

Key risks to 'flu jab approach'

  1. Too much booking friction for patients

    resulting in lower uptake

  2. Manual booking process by phone

    resulting in increased practice workload

  3. Poor compliance with 4 week booster delivery

    resulting in lower vaccine effectiveness and increased practice workload in manual booking

  4. Hard to provide 'pooled capacity', due to separate booking systems

    resulting in lower vaccination availability/uptake and increased practice workload

  5. No realtime data of invited/booked/vaccinated

    resulting in poor supply chain visibility, and poor national visibility

Invitation